Kane Biotech Inc V.KNE

Alternate Symbol(s): KNBIF

Healthcare Biotechnology

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.

TSXV:KNE - Post by User

Kane Biotech Inc

Bullboard Posts

Post by TechnicalBuyon Jul 12, 2013 10:22am

264 Views

Post# 21604061

Medicago bought out for $357m

Good morning,

Medicago got bought out for $357m this am. This is a great development for the Canadian biotech sectory, but also KNE as there are a number of investors invested in both companies. We will likely see some transfer of profits into this and other (ICO.V, BTI.V) stories.

TB
Follow me on twitter at [url=https://twitter.com/technicalbuy]@TechnicalBuy[/url]

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!